COVID-19 Vaccination and Myocardial Infarction: Insights from Treatment Data
Vaccination data suggests that myocardial infarction is a rare adverse event following COVID-19 vaccination, with a low incidence rate observed among vaccinated patients, highlighting the overall safety profile of COVID-19 vaccines in relation to cardiac outcomes.
December 2022
Myopericarditis Following COVID-19 Vaccination Rare, Study Finds
Myopericarditis following COVID-19 vaccination is a rare adverse event, according to an international study, providing reassurance regarding the safety profile of COVID-19 vaccines and the importance of ongoing surveillance.
November 2022
Increasing Measles Vaccine Acceptance: Importance of Public Awareness
Improving measles vaccine acceptance requires raising public awareness about the importance of vaccination and addressing misconceptions and barriers to immunization, highlighting the critical role of healthcare communication and community engagement in vaccine advocacy efforts.
November 2022
Equitable Distribution of COVID-19 Vaccine: Addressing Geographic Risks
Researchers find that equitable distribution of COVID-19 vaccine can mitigate transmission risks in different geographic areas, emphasizing the importance of global vaccine equity in controlling the spread of the virus and preventing future outbreaks.
November 2022
Continued Use of Masks Post COVID-19 Vaccination: Public Health Recommendations
Masks will continue to be an important part of non-pharmaceutical interventions post-COVID-19 vaccination, serving as a preventive measure against viral transmission, particularly in high-risk settings and during outbreaks of emerging variants.
November 2022
PAHO Urges Inclusion of COVID-19 Vaccine in Routine Vaccination Programs
The Pan American Health Organization (PAHO) emphasizes the importance of integrating the COVID-19 vaccine into routine vaccination systems to sustain immunization efforts and prevent resurgence of the virus amidst declining cases and easing restrictions.
November 2022
Shoulder Injury Following Vaccination: Incidence and Clinical Characteristics
Among more than 3.7 million vaccines administered, 371 cases of shoulder pathology following vaccination are identified, highlighting the importance of surveillance and reporting of vaccine-related adverse events to guide vaccine safety monitoring and risk assessment.
November 2022
Neurological Complications in COVID-19: Distinguishing Cause from Effect
Immune-mediated neurological events related to COVID-19 should not be attributed to vaccination, emphasizing the importance of accurate diagnosis and understanding the underlying pathophysiology of neurological complications associated with the virus.
November 2022
FDA Authorization of Second Booster Dose for COVID-19 Vaccines: Targeting High-Risk Populations
The FDA authorizes a second booster dose of COVID-19 vaccines for populations at higher risk of severe illness, hospitalization, and death, signaling a proactive approach to enhancing vaccine effectiveness and protecting vulnerable individuals from COVID-19.
November 2022
